Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Soapbox Science is coming to Oxford for the third year running thanks to a collaboration between the University of Oxford and Oxford Brookes University.

Scientists at 2017 'Soapbox Science' event

Soapbox Science is a novel public outreach platform for promoting women scientists and the science they do. Their events transform public areas into an arena for public learning and scientific debate; they follow the format of London Hyde Park’s Speaker’s Corner, which is historically an arena for public debate. The aim of Soapbox Science is to give everyone the opportunity to enjoy, learn from, heckle, question, probe, interact with and be inspired by leading scientists.

Two previous Soapbox Science events in Oxford have transformed Cornmarket Street and Magdalen College School into an arena for science communication and public interaction, and this Saturday 28 July the next event will be held at Bonn Square in Oxford from 1pm – 4pm.

A number of scientists from across the Medical Sciences Division will be taking part in this year’s Soapbox Science, exploring the following topics:

Other scientists will explore topics including robot doctors and venomous primates – find out more and come along.

Soapbox Science Oxford is a collaboration between the University of Oxford and Oxford Brookes University. It is organised by Carlyn Samuel (Interdisciplinary centre of of Conservation Science at the University of Oxford) Ravinder Kander (department of Biological and Medicinal Sciences, Oxford Brookes University) and Dong Liu (Department of Materials, University of Oxford).

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.